Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Shafer

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
AIDS Research and Human Retroviruses|July 13, 2000
HIV type 1 envelope subtype C sequences from recent seroconverters in ZimbabweM Batra, P C Tien, R W Shafer, et al.
AIDS Research and Human Retroviruses|February 19, 1999
Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in ZimbabweR W Shafer, T K Chuang, P Hsu, et al.
Nucleic Acids Research|December 11, 1999
Human immunodeficiency virus reverse transcriptase and protease sequence databaseR W Shafer, D R Jung, B J Betts, et al.
Nucleic Acids Research|January 11, 2000
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programsR Kantor, R Machekano, M J Gonzales, et al.
Journal of Virology|June 15, 2004
Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayAmit Kapoor, Morris Jones, R W Shafer, et al.
The Journal of Infectious Diseases|April 1, 1995
Clarification of a method to reverse transcribe human immunodeficiency virus RNAM J Kozal, R W Shafer, M A Winters, et al.
The Journal of Infectious Diseases|March 1, 1993
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipientsM J Kozal, R W Shafer, M A Winters, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 yearsM A Winters, R W Shafer, R A Jellinger, et al.
Lancet (London, England)|April 20, 1985
Possible risk of steroid administration in patients at risk for AIDSR W Shafer, K Offit, N T Macris, et al.
Journal of Clinical Microbiology|February 1, 1997
Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasmaR W Shafer, D J Levee, M A Winters, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
AIDS Research and Human Retroviruses|July 13, 2000
HIV type 1 envelope subtype C sequences from recent seroconverters in ZimbabweM Batra, P C Tien, R W Shafer, et al.
AIDS Research and Human Retroviruses|February 19, 1999
Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in ZimbabweR W Shafer, T K Chuang, P Hsu, et al.
Nucleic Acids Research|December 11, 1999
Human immunodeficiency virus reverse transcriptase and protease sequence databaseR W Shafer, D R Jung, B J Betts, et al.
Nucleic Acids Research|January 11, 2000
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programsR Kantor, R Machekano, M J Gonzales, et al.
Journal of Virology|June 15, 2004
Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayAmit Kapoor, Morris Jones, R W Shafer, et al.
The Journal of Infectious Diseases|April 1, 1995
Clarification of a method to reverse transcribe human immunodeficiency virus RNAM J Kozal, R W Shafer, M A Winters, et al.
The Journal of Infectious Diseases|March 1, 1993
A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipientsM J Kozal, R W Shafer, M A Winters, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 yearsM A Winters, R W Shafer, R A Jellinger, et al.
Lancet (London, England)|April 20, 1985
Possible risk of steroid administration in patients at risk for AIDSR W Shafer, K Offit, N T Macris, et al.
Journal of Clinical Microbiology|February 1, 1997
Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasmaR W Shafer, D J Levee, M A Winters, et al.
Pageof 7